Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

NVOS

Novo Integrated Sciences Inc

May 30 • 04:00PM ET

0.4510

Dollar change -0.0065
Percentage change -1.42	%

Healthcare • Medical Care Facilities • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.74	Insider Own	6.82%	Shs Outstand	15.76M	Perf Week	-3.43%
Market Cap	7.58M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	15.67M	Perf Month	-26.92%
Income	-12.08M	PEG	-	EPS next Q	-	Inst Own	5.17%	Short Float	3.43%	Perf Quarter	-28.51%
Sales	13.66M	P/S	0.56	EPS this Y	-	Inst Trans	8.10%	Short Ratio	0.62	Perf Half Y	-66.59%
Book/sh	1.25	P/B	0.36	EPS next Y	-	ROA	-33.83%	Short Interest	0.54M	Perf Year	-63.18%
Cash/sh	0.04	P/C	11.66	EPS next 5Y	-	ROE	-48.89%	52W Range	0.42 - 5.38	Perf YTD	-45.07%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-5.05%	ROI	-50.58%	52W High	-91.62%	Beta	-0.77
Dividend TTM	-	Quick Ratio	0.41	Sales past 5Y	8.20%	Gross Margin	36.68%	52W Low	8.41%	ATR (14)	0.06
Dividend Ex-Date	-	Current Ratio	0.50	EPS Y/Y TTM	82.98%	Oper. Margin	-68.69%	RSI (14)	42.22	Volatility	9.29% 12.98%
Employees	230	Debt/Eq	0.24	Sales Y/Y TTM	-	Profit Margin	-88.48%	Recom	-	Target Price	-
Option/Short	No / No	LT Debt/Eq	0.08	EPS Q/Q	73.29%	Payout	-	Rel Volume	5.96	Prev Close	0.46
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	24.02%	Earnings	Jan 22 AMC	Avg Volume	867.68K	Price	0.45
SMA20	-13.91%	SMA50	-12.46%	SMA200	-66.84%	Trades		Volume	5,170,001	Change	-1.42%

May-30-24 04:30PM	Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program (Business Wire)
Apr-15-24 10:53PM	NVOS Stock Earnings: Novo Integrated Sciences Reported Results for Q2 2024 (InvestorPlace)
04:30PM	Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results (Business Wire)
Apr-11-24 05:00PM	Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement (Business Wire)
10:00AM	CRAIG D. LINDER SELECTED TO 2024 TOP 50 LAWYERS IN AMERICA (PR Newswire)
02:30PM	Loading…
Mar-26-24 02:30PM	Novo Integrated Sciences Provides Update on Certain Current Actions and Events (Business Wire) -5.45%
Feb-21-24 04:05PM	Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd. (Business Wire)
Feb-20-24 02:00PM	Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note (Business Wire)
Feb-16-24 02:00PM	Novo Integrated Sciences Appoints New President (Business Wire) +13.16%
Jan-22-24 04:30PM	Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results (Business Wire) +10.51%
Dec-19-23 04:30PM	Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated Sciences (Business Wire)
Dec-14-23 11:03PM	NVOS Stock Earnings: Novo Integrated Sciences Reported Results for Q4 2023 (InvestorPlace)
05:00PM	Novo Integrated Sciences Reports 2023 Fiscal Year Financial Results (Business Wire)
Dec-05-23 12:00PM	Novo Integrated Sciences Signs Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India (Business Wire)
Dec-04-23 11:30AM	Novo Integrated Sciences Purchase and Sale Agreement to Acquire Ophir Collection Receives Court Approval (Business Wire) +18.58%
09:20AM	Loading…
Nov-24-23 09:20AM	Novo Integrated Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement (Business Wire) +13.57%
Nov-06-23 11:45AM	Novo Integrated Sciences Announces Reverse Stock Split (Business Wire) -59.50%
06:00AM	Novo Integrated Sciences Advised Receipt of Proceeds of RC Consulting Promissory Note Expected in 3-5 Business Days (Business Wire)
Nov-03-23 01:15PM	Novo Integrated Sciences Announces Issuance of Underlying One Billion Dollar Gold Backed Bond (Business Wire) +15.28%
Oct-24-23 04:30PM	Novo Integrated Sciences Board of Directors Approves $5 Million Stock Repurchase Program (Business Wire)
Oct-06-23 09:00AM	Novo Integrated Sciences Provides Update on Certain Current Events (Business Wire) -31.64%
Sep-28-23 04:15PM	Novo Integrated Sciences Signs Master Collateral Transfer Agreement (Business Wire) -15.37%
Sep-21-23 02:00PM	Novo Integrated Sciences Provides Update on Certain Current Actions and Events (Business Wire)
Sep-13-23 04:05PM	Novo Integrated Sciences IoNovo for Kids Granted Registration Number and Regulatory Approval by Turkeys Ministry of Health (Business Wire) +13.06%
Sep-08-23 09:00AM	Novo Integrated Sciences Provides Update on Potential Share Repurchase Program (Business Wire) -5.81%
Aug-31-23 04:05PM	Novo Integrated Sciences Receives Underwriter Clearance Notice for $70,000,000 Coupon (Business Wire)
Aug-24-23 09:00AM	Acenzia Selected to join Team Canada Trade Mission to India (Business Wire) -9.00%
Aug-22-23 09:00AM	Novo Integrated Sciences IoNovo Iodine Granted Registration Number and Regulatory Approval by Turkeys Ministry of Health (Business Wire) +7.48%
Aug-15-23 02:30PM	Novo Integrated Sciences Provides Update on Certain Current Actions and Events (Business Wire) +63.61%
09:00AM	Novo Integrated Sciences and Farm 7 Group Announce Joint Venture for Kenya Cooperative Agricultural Project (Business Wire)
04:15PM	Loading…
Jul-17-23 04:15PM	Novo Integrated Sciences Reports Fiscal Year 2023 Third Quarter Financial Results (Business Wire)
Jun-06-23 08:00AM	Novo Integrated Sciences Receives $40,000,000 Commitment to Develop Eldercare Facilities in Canada (Business Wire) +16.30%
May-26-23 05:00PM	Novo Integrated Sciences Reports Fiscal Year 2023 Second Quarter Financial Results (Business Wire)
06:32AM	Novo Integrated Sciences First Quarter 2023 Earnings: US$0.12 loss per share (vs US$0.067 loss in 1Q 2022) (Simply Wall St.)
May-24-23 04:30PM	Novo Integrated Sciences Reports Fiscal Year 2023 First Quarter Financial Results (Business Wire) -7.11%
Apr-27-23 08:00AM	Novo Integrated Sciences Signs Agreements for an Unsecured, Non-dilutive Debt Instrument with a Principal Sum of $70,000,000 (Business Wire) +21.73%
Apr-03-23 05:20PM	Novo Integrated Sciences Reports Fiscal Full Year 2022 Financial Results (Business Wire)
Mar-24-23 09:00AM	Novo Integrated Sciences Provides Update on Certain Current Actions and Events (Business Wire) +8.63%
Jan-30-23 04:30PM	Novo Integrated Sciences Announces Receipt of Notice from Nasdaq (Business Wire)
Jan-17-23 09:25AM	Novo Integrated Sciences Provides Update on Certain Current Actions and Events (Business Wire) -9.05%
Dec-21-22 04:30PM	Novo Integrated Sciences Announces Receipt of Notice from Nasdaq (Business Wire)
Nov-30-22 08:00AM	Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Consulting Agreement with Pharmaceutical Research & Development Company, Sarfez Pharmaceuticals, Inc. (Business Wire)
Nov-08-22 08:00AM	Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Smart Healthcare Solution Provider, TiaTech USA Inc. (Business Wire)
Oct-25-22 08:00AM	Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Tranquility Lifestyle Solutions (Business Wire)
Oct-13-22 08:30PM	Novo Integrated Sciences, Inc. Announces Pricing of $2.0 Million Public Offering (Business Wire) +12.07%
Oct-12-22 08:00AM	Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Consulting Services Agreement with Information Technology Company, Softhread (Business Wire) -18.93%
Aug-09-22 06:30AM	Embracing Technology and Innovation "Key" to Easing Healthcare Crisis (Business Wire) -5.79%
Jul-14-22 04:05PM	Novo Integrated Sciences Reports Record Revenue of $13.8 million in Fiscal 2022 Third Quarter (Business Wire) +9.04%
Jul-11-22 04:05PM	Novo Integrated Sciences Announces Preliminary Revenue Range for Fiscal 2022 Third Quarter (Business Wire)
Jun-23-22 08:00AM	Novo Integrated Sciences Chairman and CEO to Present at the AAPI CEO Forum on the Future of Healthcare: Technology, Transformation and Beyond (Business Wire)
Apr-26-22 08:00AM	Novo Integrated Sciences Chief Medical Officer, Dr. Joseph M. Chalil, Selected as Top Physician of the Year by IAOTP (Business Wire)
Apr-13-22 04:05PM	Novo Integrated Sciences Reports Fiscal 2022 Second Quarter Financial Results (Business Wire) +7.79%
Apr-07-22 08:00AM	Novo Integrated Sciences Completes Acquisition of Clinical Consultants International LLC (Business Wire)
Mar-29-22 08:00AM	Novo Integrated Sciences Signs Memorandum of Understanding with Boditech Med, a Global Point-of-Care Testing Leader, to Market and Distribute in North America (Business Wire) +5.78%
Mar-24-22 08:00AM	Novo Integrated Sciences PRO-DIP® Issued U.S. Patent for Oral Pouch Delivery System Technology (Business Wire) -16.28%
Mar-23-22 08:00AM	Novo Integrated Sciences Enters into Purchase Agreement to Acquire Clinical Consultants International LLC (Business Wire)
Mar-16-22 08:00AM	Novo Integrated Sciences to Participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest (Business Wire) +8.00%
Mar-08-22 08:00AM	Novo Integrated Sciences IoNovo Iodide Granted Natural Product Number (NPN) by Health Canada (Business Wire) +6.71%
Feb-18-22 08:00AM	Novo Integrated Sciences IoNovo for Kids Pure Iodine Oral Spray Granted Natural Product Number (NPN) by Health Canada (Business Wire)
Jan-18-22 04:05PM	Novo Integrated Sciences Reports First Quarter Financial Results (Business Wire)
Jan-14-22 08:00AM	Novo Integrated Sciences Announces the Signing of a Master Facility License Agreement with LA Fitness in Canada (Business Wire) -5.40%
Dec-23-21 08:00AM	Novo Integrated Sciences Granted Natural Product Number (NPN) by Health Canada for IoNovo Iodine Branded Product (Business Wire)
Dec-14-21 06:23PM	Novo Integrated Sciences Reports Fiscal Full Year 2021 Financial Results (Business Wire)
Nov-30-21 08:00AM	Novo Integrated Sciences Acquires Majority Stake in Terragenx and Intellectual Property for FDA and Health Canada Approved Water-Soluble Iodine Micro-Nutrient (Business Wire) +10.77%
Oct-14-21 08:00AM	Novo Integrated Sciences subsidiary, Novo Healthnet Limited, and EK-Tech Solutions Announce Joint Venture for Enhanced Telehealth Platform (Business Wire)
Sep-23-21 08:00AM	Novo Integrated Sciences to Present at the Benzinga Virtual Global Healthcare Small Cap Conference on September 30th (Business Wire) -7.69%
Aug-30-21 08:00AM	Novo Integrated Sciences Signs LOIs to Acquire Seven Pharmacies in the United States (Business Wire)
Aug-18-21 08:00AM	Novo Integrated Sciences Subsidiary, Acenzia, Signs Exclusive Licensing Agreement with Performance Inspired Nutrition to Manufacture and Distribute in the Middle East (Business Wire)
Jul-16-21 05:37AM	Novo Integrated Sciences'(NASDAQ:NVOS) Share Price Is Down 69% Over The Past Three Years. (Simply Wall St.)
Jul-14-21 04:05PM	Novo Integrated Sciences Announces Third Quarter 2021 Financial Results (Business Wire)
Jul-07-21 08:00AM	Novo Integrated Sciences Appoints Dr. Indrajit (Indra) Sinha Ph.D. as Chief Science Officer (Business Wire) -5.98%
Jun-29-21 08:00AM	Novo Integrated Sciences and Novo Healthnet Limited Complete Acquisition of Acenzia (Business Wire)
Jun-03-21 08:00AM	Novo Integrated Sciences Enters into Share Exchange Agreement to Acquire Acenzia Inc. (Business Wire)
May-26-21 08:00AM	Novo Integrated Sciences Completes Acquisition of PRO-DIP, LLC (Business Wire)
May-17-21 08:00AM	Novo Integrated Sciences Enters into Share Exchange Agreement to Acquire PRO-DIP, LLC (Business Wire)
Apr-22-21 08:00AM	Novo Integrated Sciences Announces Formation of Medical Advisory Board (Business Wire) +9.68%
Apr-15-21 08:00AM	Novo Integrated Sciences Announces Closing of $8 Million Registered Direct Offering (Business Wire) -6.52%
Apr-14-21 04:05PM	Novo Integrated Sciences Announces Second Quarter 2021 Financial Results (Business Wire)
Apr-09-21 08:55AM	Novo Integrated Sciences Announces Pricing of $8.0 Million Registered Direct Offering (Business Wire) -24.10%
Apr-06-21 08:00AM	Novo Integrated Sciences Announces Preliminary Revenue and Financial Results of Second Quarter Fiscal Year 21 (Business Wire)
Mar-17-21 08:00AM	Novo Integrated Sciences to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference, March 17-19, 2021 (Business Wire)
Mar-02-21 04:00AM	Does Novo Integrated Sciences (NASDAQ:NVOS) Have A Healthy Balance Sheet? (Simply Wall St.) -8.76%
Mar-01-21 08:00AM	Novo Integrated Sciences Announces New Executive Hires for Novo Healthnet Limited (Business Wire) -5.76%
Feb-24-21 10:28AM	Novo Integrated Sciences stock surges, but pulls back sharply in volatile trading (MarketWatch) +59.70%
Feb-22-21 02:00PM	Novo Integrated Sciences Announces Uplist to The Nasdaq Capital Market (Business Wire) +11.11%
Feb-04-21 08:00AM	Novo Integrated Sciences Announces New President of Novo Healthnet Limited (Business Wire) -28.86%
Feb-01-21 08:03AM	Novo Integrated Sciences Effects Reverse Stock Split in Connection with Nasdaq Capital Market Listing Application (Business Wire)
Jan-28-21 08:00AM	Novo Integrated Sciences Announces Three New Independent Directors Appointed to its Board of Directors and Formation of an Audit Committee (Business Wire) +91.74%
Nov-18-20 08:00AM	Novo Integrated Sciences, Inc. Engages Investor Acquisition Advisors (Newsfile) -5.26%
Aug-11-20 08:00AM	Novo Integrated Sciences Engages Maxim Group LLC to Assist with its Growth Strategy and Goal to Up-list to a National Exchange (Newsfile) -15.25%
Mar-20-20 04:00PM	Novo Integrated Sciences Provides Business Impact of COVID-19 Pandemic (Newsfile) -6.25%

Novo Integrated Sciences, Inc. engages in the provision of medical services. The firm offers specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology, and dental services. Its multi-disciplinary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation, and prevention through its clinics, affiliate clinics, retirement homes, and long-term facilities. The firm operates through the Healthcare Services and Product Sales segments. The company was founded by Michael H. Rouse on November 27, 2000 and is headquartered in Bellevue, WA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVOS

Novo Integrated Sciences Inc

Upgrade your FINVIZ experience